Hereditary Hemochromatosis: Absorbing Too Much Iron from Food
Hereditary hemochromatosis is a genetic condition characterized by the excessive absorption of iron from food by the body. This disorder leads to the progressive accumulation of excess iron in various organs and tissues, particularly the liver, pancreas, and heart.
What is hereditary hemochromatosis?
The main aspects of hereditary hemochromatosis are:
It is caused by mutations in the HFE gene, which regulates intestinal iron absorption.
It is genetically transmitted, requiring the inheritance of the mutated gene from both parents.
It leads to the slow accumulation of iron in the body over several years.
Symptoms usually appear after the age of 40-50 in men and after menopause in women.
It can lead to severe damage to the organs where excess iron is deposited.
A characteristic manifestation of the disease is the so-called bronze diabetes, which associates diabetes mellitus with skin hyperpigmentation due to iron deposits. Other symptoms may include chronic fatigue, joint pain, liver, and heart damage.
Early diagnosis and appropriate treatment with regular phlebotomies can prevent severe complications of hereditary hemochromatosis and ensure a normal life expectancy for patients.
Causes of hereditary hemochromatosis
The main cause of hereditary hemochromatosis is a genetic mutation that affects how the body absorbs and processes iron. This condition is based on the following aspects:
Mutations in the HFE gene, located on chromosome 6, which regulates intestinal iron absorption
The most common mutations are C282Y and H63D.
Autosomal recessive transmission – the inheritance of the mutated gene from both parents is necessary to develop the disease.
Insufficient production of hepcidin, the hormone that controls iron levels in the body.
Increased and uncontrolled intestinal absorption of iron from food.
There are several types of hereditary hemochromatosis, depending on the genes affected:
- Type 1 (classic form) – caused by mutations in the HFE gene;
- Type 2 (juvenile form) – caused by mutations in the hemojuvelin or hepcidin genes;
- Type 3 – involving mutations in the transferrin receptor 2 gene;
- Type 4 (ferroportin disease) – caused by mutations in the SLC40A1 gene.
Factors that increase the risk of developing hereditary hemochromatosis include:
- Northern European ethnic origin, particularly Celtic;
- Male sex – men are affected more frequently and earlier than women;
- Family history of hemochromatosis;
- Excessive alcohol consumption – can accelerate disease progression.
Understanding the genetic causes of hereditary hemochromatosis is essential for early diagnosis and appropriate management of this condition.
Symptoms of hemochromatosis
Hemochromatosis manifests through a wide range of symptoms, which usually appear after the age of 40-50 in men and after menopause in women.
The main symptoms of hemochromatosis include:
- Chronic fatigue and generalized weakness;
- Joint pain, especially in the hands;
- Abdominal pain;
- Weight loss;
- Decreased libido and erectile dysfunction in men;
- Absence of menstrual cycle in women;
- Skin hyperpigmentation (bronzed appearance).
As the disease progresses, more severe complications may occur, such as:
- Bronze diabetes – the association between diabetes mellitus and bronzed skin coloration;
- Liver damage (hepatomegaly, cirrhosis);
- Heart failure and arrhythmias;
- Arthropathies (especially in small joints);
- Hypothyroidism;
- Hypogonadism.
In addition to medication, Liposomal Vitamin C 1000mg – 60 capsules with over 99% absorption capacity in the body is an excellent source for well-being.
This dietary supplement provides your daily recommended dose of Vitamin C, essential for overall health. Due to its innovative liposomal form, Vitamin C is absorbed directly into the body’s cells, ensuring maximum efficacy and superior benefits for body and mind.
This effective supplement helps strengthen the immune system, protects skin, teeth, and brain, and supports mental health. It also has proven benefits against anemia, fatigue, depression, and gout, offering valuable support in maintaining general well-being.
Due to its liposomal coating, Vitamin C is protected from external factors such as light, heat, and oxidation, which preserves its efficacy and benefits for a longer period. The capsules are suitable for various diets, being free from gluten, lactose, preservatives, or artificial colors.
It is recommended to follow the daily dose of 2 capsules, without exceeding it. Consistent administration is essential to correct Vitamin C deficiency in the body and allow the body to fully assimilate the benefits of this supplement.
[cta_produs style=”style_1″ product=”302950″ image=”https://aronia-charlottenburg.com/wp-content/uploads/2025/02/Simptomele-hemocromatozei_Vitamina-C-Lipozomala.jpg”]
It is important to note that the symptoms of hemochromatosis are nonspecific in the early stages and can be mistaken for other conditions. Therefore, early diagnosis through blood tests and genetic tests is essential to prevent severe complications.
Diagnosis of hereditary hemochromatosis
The diagnosis of hereditary hemochromatosis involves several stages and investigations to confirm the presence of the disease and assess the degree of iron accumulation in the body. The main diagnostic methods include:
Blood tests
Blood tests are essential for the initial assessment of iron levels:
– Transferrin saturation coefficient – a value above 45% is suggestive of hereditary hemochromatosis;
– Serum ferritin – elevated levels indicate iron accumulation in tissues;
– Sideremia – measures the amount of circulating iron.
Genetic tests
Genetic testing is the gold standard for diagnosing this condition:
– HFE gene mutations are sought, particularly C282Y and H63D;
– C282Y homozygous status is the major diagnostic criterion;
– In the absence of HFE mutations, other involved genes can also be tested.
Imaging studies
To assess iron deposits in organs, the following may be performed:
Liver MRI – allows non-invasive quantification of liver iron.
Abdominal CT – may reveal liver changes.
Hepatic biomagnetic susceptometry – a sensitive method for measuring liver iron.
Liver biopsy
Although invasive, liver biopsy provides valuable information:
Confirms the presence of excess iron deposits.
Assesses the degree of liver damage (fibrosis, cirrhosis).
Excludes other causes of liver disease.
An early diagnosis of hereditary hemochromatosis is essential for prompt initiation of treatment and prevention of severe complications. Specialist physicians correlate clinical, laboratory, and imaging data to establish a final diagnosis and develop an appropriate therapeutic plan.
Treatment of hemochromatosis
The primary treatment for hemochromatosis is phlebotomy, a procedure similar to blood donation. Its purpose is to reduce iron levels in the body by regularly removing a quantity of blood.
Therapeutic phlebotomy in treating hemochromatosis
Therapeutic phlebotomy involves the following aspects:
Approximately 500 ml of blood is drawn once or twice a week in the initial phase.
Treatment continues until iron levels reach normal limits.
50-100 phlebotomies may be required to normalize iron levels.
After normalization, maintenance phlebotomies are performed (3-4 times a year).
The therapeutic goal is to maintain ferritin levels below 50 mcg/l.
Iron chelator therapy in treating hemochromatosis
In cases where phlebotomy is not possible, iron chelator therapy can be used:
Medications that bind excess iron in the blood are administered.
The bound iron is then eliminated through urine or stool.
It can be administered orally or injectably.
It is a secondary option, less effective than phlebotomy.
Treatment of complications in treating hemochromatosis
In addition to reducing iron levels, treatment also aims to manage complications associated with hemochromatosis, such as:
– Treatment of bronze diabetes with insulin or oral antidiabetic drugs;
– Management of liver conditions, including cirrhosis;
– Treatment of heart failure and arrhythmias;
– Therapy for joint conditions.
Lifestyle modifications in treating hemochromatosis
Patients with hemochromatosis should adopt certain measures to limit iron intake and absorption:
- Limit alcohol consumption to prevent liver damage;
- Avoid consumption of red meat and raw seafood;
- Drink tea and coffee, which can reduce iron absorption.
With appropriate treatment and regular monitoring, most patients with hemochromatosis can have a normal life expectancy and prevent severe complications of the disease.
Complications and prognosis for hereditary hemochromatosis
Untreated hereditary hemochromatosis can lead to a series of serious complications affecting multiple organs and systems:
Liver complications
– Liver fibrosis and cirrhosis – present in about 70% of untreated cases;
– Hepatocellular carcinoma – the risk is up to 200 times higher than in the general population;
– Liver failure.
Endocrine complications
– Diabetes mellitus – occurs in about 50% of cases;
– Secondary hypogonadism;
– Hypothyroidism;
– Adrenal insufficiency.
Cardiovascular complications
– Cardiomyopathy;
– Congestive heart failure;
– Cardiac arrhythmias.
Other complications
– Severe arthropathies, especially in small joints;
– Osteoporosis;
– Cutaneous hyperpigmentation (bronzed appearance of the skin).
The prognosis of hereditary hemochromatosis largely depends on the timing of diagnosis and initiation of treatment:
Early diagnosis and prompt treatment can prevent the onset of complications and ensure a normal life expectancy.
In cases diagnosed late, after the onset of cirrhosis or diabetes, the prognosis is guarded.
The main causes of death are liver failure, hepatocellular carcinoma, and cardiac complications.
An important aspect to mention is that phlebotomy treatment can significantly improve some complications, such as diabetes mellitus or heart failure, if initiated early. However, advanced liver damage and arthropathies are usually irreversible.
Close monitoring and periodic screening for hepatocellular carcinoma are essential in affected individuals. This includes after normalizing iron levels, to ensure optimal long-term management of the disease.
Prevention and management of hereditary hemochromatosis
Effective prevention and management of hemochromatosis are essential to avoid serious complications of this condition. Here are some key aspects to consider:
Screening and early diagnosis
– Genetic testing for HFE gene mutations in first-degree relatives of diagnosed patients;
– Regular monitoring of serum iron and ferritin levels in individuals at increased risk;
– Periodic liver function tests to detect early liver damage.
Treatment and monitoring
– Regular therapeutic phlebotomies to maintain optimal iron levels;
– Close monitoring of serum ferritin and transferrin saturation coefficient values;
– Periodic evaluation of liver, cardiac, and endocrine function;
– Prompt treatment of complications such as bronze diabetes, arthropathy, or cardiomyopathy.
Patient education
A crucial aspect in managing hemochromatosis is patient education regarding:
- The importance of adherence to phlebotomy treatment;
- Recognizing signs and symptoms that require immediate medical attention;
- The necessity of informing doctors about the hemochromatosis diagnosis when dealing with other health issues.
By implementing these prevention and management measures, individuals with hemochromatosis can maintain a good quality of life and significantly reduce the risk of severe complications, including the development of bronze diabetes.
Role of vitamin C in managing hemochromatosis
In the context of hemochromatosis, vitamin C plays a complex role. On one hand, vitamin C can increase iron absorption, which could be problematic for patients with hemochromatosis. On the other hand, vitamin C has important antioxidant properties that can help protect the body against the oxidative stress caused by excess iron.
If you wish to benefit from the antioxidant effects of vitamin C without significantly increasing iron absorption, Liposomal Vitamin C 1000mg – 60 capsules with over 99% absorption capacity in the body is an optimal source.
[cta_produs style=”style_2″ product=”302950″ image=”https://aronia-charlottenburg.com/wp-content/uploads/2025/02/Rolul-vitaminei-C-in-gestionarea-hemocromatozei_Fier-si-Vitamina-C-Lipozomale-detalii-ambientale.jpg”]
Potential benefits of vitamin C for patients with hemochromatosis include:
- Antioxidant protection against oxidative stress caused by excess iron.
- Support for the immune system, which can be affected in hemochromatosis.
- Contribution to collagen synthesis, important for joint health, which can be affected in hemochromatosis.
- Potential for improving the absorption of other essential nutrients.
It is important to note that while liposomal vitamin C can offer benefits, it does not replace standard treatment for hemochromatosis, which remains therapeutic phlebotomy. Vitamin C supplementation is an adjuvant therapy.
Therefore, by adopting a holistic approach that combines standard medical treatment with lifestyle improvement strategies and psychosocial support, the quality of life can be significantly improved. It is important that each care plan be personalized according to the individual needs and circumstances of the patient, under the careful guidance of a specialized medical team.
References
- Adams PC, Barton JC. How I treat hemochromatosis. Blood. 2010;116(3):317-325.
- Bacon BR, Adams PC, Kowdley KV, Powell LW, Tavill AS. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology. 2011;54(1):328-343.
- European Association for the Study of the Liver. EASL clinical practice guidelines for HFE hemochromatosis. J Hepatol. 2010;53(1):3-22.
- Powell LW, Seckington RC, Deugnier Y. Haemochromatosis. Lancet. 2016;388(10045):706-716.
- Milman NT, Schioedt FV, Junker AE, Magnussen K. Diagnosis and Treatment of Genetic HFE-Hemochromatosis: The Danish Aspect. Gastroenterology Res. 2019;12(5):221-232.
Photo credit: shutterstock.com